This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Oscar H. Del Brutto, MD
Department of Neurology Luis Vernaza Hospital PO Box (09-01) 3734 Guayaquil, Ecuador South America

Arch Neurol. 1993;50(4):348.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We described four patients with giant subarachnoid cysticerci who were successfully treated with albendazole.¹ As noted in our article, the patients did not have intracranial hypertension or hydrocephalus before the trial, and dexamethasone treatment was started before albendazole administration and its use was prolonged some days after that trial had been completed. Therefore, our patients differ from that described by Noboa in both the clinical picture and the timing of dexamethasone administration. Probably, such differences accounted for the "deleterious effect of albendazole" reported in Noboa's letter.

When our article was submitted for publication in the ARCHIVES, I was working at the Ecuadorian Institute of Social Security. Now, as a member of the Department of Neurology of Luis Vernaza Hospital (Guayaquil, Ecuador), I have had the opportunity to review the record of the patient described by Noboa. The patient was totally blind before albendazole administration, and funduscopic examination . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?